Tickers

CDW — Ticker Eval done nvidia/nemotron-3-ultra-550b-a55b:free

Requested 2026-09-22 10:59:10.763075 UTC · finished 2026-09-22 11:07:26.374032 UTC

1. Composite Trajectory Verdict

Given CDW's role as a high-volume, low-margin IT solutions distributor, cash generation and working capital efficiency (cash flow statement and balance sheet) are most critical for assessing financial performance, though earnings trends provide context on margin sustainability.

Composite Trajectory: Mixed

Revenue growth has resumed at double-digit rates in the first half of 2026 (10-Q 2026-06-30, MD&A Results of Operations) and full-year 2025 (10-K 2025-12-31, Consolidated Statements of Operations), but this top-line improvement is offset by persistent gross and operating margin compression across both annual and quarterly periods. Operating cash flow has declined for three consecutive years and fell 50% year-over-year in the first half of 2026, while the cash conversion cycle has widened from 16 to 21 days. The balance sheet shows equity growth and a modest reduction in net debt at year-end 2025, but quarterly net debt has risen and working capital pressures have intensified. These opposing forces — revenue momentum versus margin erosion and cash flow deterioration — produce a mixed overall trajectory.

2. Red Flags

  • Operating cash flow has declined for three straight years: $1,598.7M (2023) → $1,277.3M (2024) → $1,205.2M (2025) (10-K 2025-12-31, Consolidated Statements of Cash Flows).
  • Cash conversion cycle increased from 18 days (Dec 2024) to 16 days (Dec 2025) to 21 days (June 2026) versus 16 days a year earlier (10-K 2025-12-31, MD&A Liquidity and Capital Resources; 10-Q 2026-06-30, MD&A Liquidity and Capital Resources).
  • Gross margin compression in every comparable period: annual -20 bps (2025 vs 2024), quarterly -70 bps (Q2 2026 vs Q2 2025), six-month -60 bps (10-K 2025-12-31, MD&A Key Business Metrics; 10-Q 2026-06-30, MD&A Results of Operations).
  • Operating margin compression: annual -50 bps (2025 vs 2024), quarterly -50 bps (Q2 2026 vs Q2 2025) (same sources).
  • Net income declined annually despite 2025 revenue growth: $1,104.3M (2023) → $1,077.8M (2024) → $1,066.6M (2025) (10-K 2025-12-31, Consolidated Statements of Operations).
  • Accounts receivable growing faster than sales: current AR +22.9% YoY (Dec 2025 vs Dec 2024) while net sales rose 6.8% (10-K 2025-12-31, Consolidated Balance Sheets and Statements of Operations).
  • Merchandise inventory surged 74% to $981.8M at June 30, 2026 from $563.4M at Dec 31, 2025 (10-Q 2026-06-30, Consolidated Balance Sheets).
  • "Workplace optimization" charges recur across periods: $25.4M (2024), $16.2M (2025), $44.2M (H1 2026) (10-K 2025-12-31, Non-GAAP Reconciliation; 10-Q 2026-06-30, Non-GAAP Reconciliation).
  • Share repurchases increased to $653M in 2025 from $500M in 2024 while operating cash flow fell (10-K 2025-12-31, MD&A Liquidity and Capital Resources; Consolidated Statements of Cash Flows).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Mixed

Annual revenue dipped 1.8% in 2024 then rebounded 6.8% in 2025 to $22,424.1M, surpassing the 2023 level (10-K 2025-12-31, Consolidated Statements of Operations). However, gross margin fell 20 bps to 21.7% in 2025 and operating margin contracted 50 bps to 7.4%, leaving operating income essentially flat at $1,655.6M versus $1,651.3M. Net income slipped 1.0% to $1,066.6M. In the first half of 2026, net sales grew 9.6% year-over-year to $12,252.0M, but gross margin dropped 60 bps to 20.5% and operating margin fell 40 bps to 6.6%; operating income rose only 2.9% and net income 2.8% (10-Q 2026-06-30, MD&A Results of Operations). The consistent pattern is revenue growth failing to translate into proportional profit growth due to hardware mix shift and pricing pressure.

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Deteriorating

Operating cash flow has fallen in each of the last three years, dropping 20% from 2023 to 2024 and a further 5.6% from 2024 to 2025 (10-K 2025-12-31, Consolidated Statements of Cash Flows). The first half of 2026 saw a sharp 50% decline to $219.7M from $443.1M, driven by a $1.05B increase in accounts receivable and a $418M inventory build, only partially offset by higher accounts payable (10-Q 2026-06-30, Consolidated Statements of Cash Flows). Adjusted free cash flow, which was roughly flat annually ($1,079.0M in 2024 vs $1,085.5M in 2025), plunged 39% to $278.4M in H1 2026 from $458.9M (10-K 2025-12-31, MD&A Key Business Metrics; 10-Q 2026-06-30, MD&A Key Business Metrics). The cash conversion cycle widened to 21 days at June 30, 2026 from 16 days a year earlier, reflecting higher DSO and DIO (10-Q 2026-06-30, MD&A Liquidity and Capital Resources).

5. Balance Sheet Assessment

Balance Sheet Trajectory: Mixed

At year-end 2025, total assets rose 9.2% to $16,028.2M, equity increased 10.8% to $2,606.1M, and net debt declined 2.2% to $5,011.1M (10-K 2025-12-31, Consolidated Balance Sheets; MD&A Key Business Metrics). However, current accounts receivable jumped 22.9% to $6,312.4M, outpacing sales growth. By June 30, 2026, net debt had risen to $5,455.2M, cash fell to $361.8M from $618.7M at year-end, and merchandise inventory nearly doubled to $981.8M (10-Q 2026-06-30, MD&A Key Business Metrics; Consolidated Balance Sheets). The cash conversion cycle deterioration and receivables/inventory buildup signal mounting working capital pressure, even as the capital structure remains solid with $1.7B revolver availability.

6. Data Gaps

  • Quarterly income statements for Q1 2026, Q3 2025, and Q2 2025 (only six-month and Q2 2026 figures are disclosed in the provided 10-Qs).
  • Quarterly cash flow statements for three-month periods (only six-month aggregates provided in 10-Q 2026-06-30).
  • Balance sheet as of June 30, 2025 (needed for quarterly YoY comparison of working capital and leverage).
  • Segment operating income for the new Commercial/Government/Education structure prior to 2026 (prevents comparable segment trend analysis).
  • Full non-GAAP reconciliations for quarterly periods before 2026.
  • Quantification of potential liability from the DOJ Civil Investigative Demand noted in Note 16 (10-K 2025-12-31, Commitments and Contingencies).
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short. JSON: /api/signals · /api/funds · /api/status